Skip to main content
TipRanks
Go Ultimate75% OFF

Ignace Robert Goethals Insider Profile

4 Followers

Ignace Robert Goethals, Director at Allergy Therapeutics, holds 5.03M shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Ignace Robert Goethals Bought 20,000 shares of Allergy Therapeutics on Apr 20, 2012 for an estimated value of ―.

Ignace Robert Goethals's Trading History

AGY
Allergy Therapeutics
Apr 20, 2012DirectorInformative Buy―£74.99K
GB:AGY
Insider Shares: 5.03M (123.69%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 20, 2012Informative Buy£0.0020,000£0.00――
Mar 29, 2011Informative Buy£9.91K115,197£9.00――
Jun 12, 2009Uninformative Sell£50.00K1,000,000£5.00――

You May Also Like

Ignace Robert Goethals insider profile FAQ

What is the percentage of profitable transactions made by Ignace Robert Goethals?
The percentage of profitable transactions made by Ignace Robert Goethals is 50%.
What is the average return per transaction made by Ignace Robert Goethals?
The average return per transaction made by Ignace Robert Goethals is 0.50%.
What stocks does Ignace Robert Goethals hold?
Ignace Robert Goethals holds: GB:AGY stocks.
What is Ignace Robert Goethals's role in Allergy Therapeutics?
Ignace Robert Goethals's role in Allergy Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.